InsidersTradesSigma
Track the ACCURAY INCORPORATED stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €31.6m. The latest transaction was filed on 12 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: LEONEL PERALTA. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
ACCURAY INCORPORATED is a company focused on developing radiation therapy systems for cancer treatment. It is listed on the XNAS market.